MD Orthopaedics Publishes Clubfoot Chronicles, One Parent’s Heartfelt and Personal Account of Life With a Clubfoot Child

MD Orthopaedics, manufacturer of the gold-standard Mitchell Ponseti® orthotic solutions for the treatment of clubfoot, announces publication of the new book Clubfoot Chronicles, written by Brand Ambassador Maureen Hoff.

Clubfoot Chronicles offers an honest and heartfelt look into the ups and downs of raising a clubfoot child. While the physician plays a key role in the manipulation and casting portion of treatment, up to 95% of clubfoot treatment is managed – at home – by the parents. New parents can quickly be overwhelmed with the demands of weekly doctor’s visits, the heavy casts, implementing daily stretches, checking that the casts and boots fit properly and simply managing the care of a newborn, especially if there are other children at home.

Upon hearing her daughter’s clubfoot diagnosis, Maureen set out to find out as much as she could about the clubfoot defect and treatment options. She spent hours on the computer, finding plenty of information about the casting phase, but very little about the bracing phase of treatment – also known as the boots-and-bar phase. This is arguably the most critical part of treatment, as non-compliance with the prescribed bracing protocol can lead to relapse of the clubfoot, but there is little information available to help uncertain parents manage this critical piece of their child’s care. It was this struggle to find the information and resources she was looking for that motivated Maureen to write the book, so that other clubfoot parents would not face the same difficulties.

Clubfoot Chronicles tells the story of Maureen’s personal struggles in caring for her child and the fear, anxiety, and stress she felt trying to manage her daughter’s care. With brutal honesty, Maureen shines a light on the many challenges clubfoot parents face and shares the many resources she uncovered that helped her cope. It is her hope that other clubfoot parents will benefit from her experiences, wisdom and research and have a smoother, easier clubfoot journey.

Maureen Hoff has her master’s degree in Marriage and Family Therapy and is passionate about clubfoot advocacy, specifically providing support and resources for other clubfoot parents. She is the mother of 3 smart and sassy girls, the last of which was born with bilateral clubfoot in 2018. Maureen recently became a Brand Ambassador for MD Orthopaedics and is working with them to create supportive content for other clubfoot parents.

Clubfoot is one of the most common musculoskeletal birth defects, affecting one out of every 100 babies born worldwide. The non-surgical Ponseti Method is the gold standard treatment, used to remedy approximately 95% of clubfoot cases worldwide. This Method is safer, less expensive, and more effective, using weekly manipulation and casting of the clubfoot to “train” it to the proper position. After the casting phase is complete, the child is fitted with an ankle-foot orthotic (AFO) to keep the manipulated foot in position. The AFO is worn for 23 hours a day for three months, then during nap and overnight sleep time for up to five years.

Clubfoot Chronicles is available in e-book format on Amazon:

The book is also available from Amazon in paperback:

The paperback will also be available at Home – MD Orthopaedics – (easyordershop.com) beginning in mid-July.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”